Trial
NCT02771457
Managing Infliximab Reinduction After Temporary Discontinuation of Drug
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
NYU Langone Health
Collaborators
—
Condition
Inflammatory Bowel Disease
Intervention
Infliximab at weeks 0,2, and 6
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-06-30